Ушбу иш иқтибос қилган ишлар

147 та иш

Иш: Chemopreventive and Anticancer Role of Resveratrol

In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery
Juan Carlos Lacal
Мақола19992 иқтибос
ABI
Dose-Dependency of Resveratrol in Providing Health Benefits
Subhendu Mukherjee, Jocelyn I. Dudley, Dipak K. Das
Мақола20102 иқтибос
ABI
Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
Jessica Plati, Octavian Bucur, Roya Khosravi‐Far
Шарҳ мақола20082 иқтибос
ABI
Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?
Moammir Hasan Aziz, Shannon Reagan‐Shaw, Jianqiang Wu +2
Мақола20052 иқтибос
ABI
Oxidative stress in malignant melanoma and non-melanoma skin cancer
Christina S. Sander, Florian Hamm, Peter Elsner +1
Мақола20032 иқтибос
ABI
Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma
Yangyang Hu, Shengpeng Wang, Xu Wu +4
Шарҳ мақола20132 иқтибос
ABI
Important Role of Autophagy in Regulation of Metabolic Processes in Health, Disease and Aging
Zuzana Papáčková, Monika Cahová
Шарҳ мақола20142 иқтибос
ABI
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
Anupam Bishayee
Шарҳ мақола20092 иқтибос
ABI
Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
Ahmed M. Al‐Abd, Alì Mokhtar Mahmoud, Gamal A. El-Sherbiny +5
Мақола20112 иқтибос
ABI
Resveratrol and P-glycoprotein Inhibitors Enhance the Anti-Skin Cancer Effects of Ursolic Acid
Jacob J. Junco, Anna Mancha, Gunjan Malik +4
Мақола20132 иқтибос
ABI
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Thomas Walle, Faye Hsieh, Mark H. DeLegge +2
Мақола20042 иқтибос
ABI
Telomerase enzymatic component hTERT shortens long telomeres in human cells
Yun‐Ling Zheng, Fan Zhang, Bing Sun +9
Мақола20142 иқтибос
ABI
Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases—Safety, Pharmacokinetics, and Pharmacodynamics
Lynne Howells, D.P. Berry, P.J. Elliott +6
Мақола20112 иқтибос
ABI
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria Brown, Ketan Patel, Maria Viskaduraki +11
Мақола20102 иқтибос
ABI
Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent
David J. Boocock, Guy Faust, Ketan Patel +9
Мақола20072 иқтибос
ABI
Reactive oxygen species in redox cancer therapy
Lingying Tong, Chia‐Chen Chuang, Shiyong Wu +1
Шарҳ мақола20152 иқтибос
ABI
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
Zhipeng Zou, Juan Chen, Jun Yang +1
Шарҳ мақола20162 иқтибос
ABI
Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies
Xun Chen, Ning Duan, Caiguo Zhang +1
Шарҳ мақола20162 иқтибос
ABI
Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
Jie Meng, Fangqin Guo, Haiyan Xu +3
Мақола20162 иқтибос
ABI
Effects of resveratrol on the proliferation, apoptosis and telomerase ability of human A431 epidermoid carcinoma cells
Xiaoxiang Zhai, JI-CUN DING, Zhiming Tang +5
Мақола20162 иқтибос
ABI
Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment
Sahdeo Prasad, Vivek R. Yadav, Bokyung Sung +3
Мақола20162 иқтибос
ABI
P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update
Xiaobo Wang, Kexin Liu
Шарҳ мақола20162 иқтибос
ABI
Effect of quercetin and resveratrol co-incorporated in liposomes against inflammatory/oxidative response associated with skin cancer
Carla Caddeo, Amparo Nácher, Antonio Vassallo +7
Мақола20162 иқтибос
ABI
Molecular signaling cascades involved in nonmelanoma skin carcinogenesis
Robert P. Feehan, Lisa M. Shantz
Шарҳ мақола20162 иқтибос
ABI
Survivin, a Promising Gene for Targeted Cancer Treatment
Fatemeh T. Shamsabadi, Mohammad Reza Akbari Eidgahi
Мақола20162 иқтибос
ABI